Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium
Journal of clinical oncology, 2023-04, Vol.41 (11), p.2087-2097 [Peer Reviewed Journal]2023 by American Society of Clinical Oncology 2023 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.22.01365 ;PMID: 36623248
Full text available